|
AU2002254400B2
|
|
Molecular conjugates for use in treatment of cancer
|
|
US6495705B2
|
|
Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
|
|
US6653501B2
|
|
Chiral resolution method for producing compounds useful in the synthesis of taxanes
|
|
US6452025B1
|
|
Three-step conversion of protected taxane ester to paclitaxel
|
|
US6479679B1
|
|
Two-step conversion of protected taxane ester to paclitaxel
|
|
AU5364201A
|
|
Paclitaxel treatment regimen for metastatic melanoma
|
|
EP1192126A1
|
|
C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof
|
|
US6358996B1
|
|
Stable isotope labeling of paclitaxel
|
|
US6281368B1
|
|
Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
|
|
AU3606600A
|
|
Treatment regimen for prostate cancer
|
|
EP1154819A2
|
|
Treatment regimen for hormone-sensitive cancers
|
|
MXPA01008352A
|
|
C-7 metal alkoxides of baccatin iii.
|
|
US6143902A
|
|
C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof
|
|
US6136999A
|
|
C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof
|
|
AU3670799A
|
|
Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-CBZ baccatin III
|
|
AU6478598A
|
|
Process of converting taxanes into baccatin III and 10-deacetylbaccatin III
|
|
US6048990A
|
|
Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
|
|
US6066749A
|
|
Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis
|
|
IL131217D0
|
|
Novel methods and compositions for delivery of taxanes
|
|
US5914411A
|
|
Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position
|
